Company intelligence / Profile preview

Kopran

Mumbai, Maharashtra, India

Ownership: Private
Development stage: Other

Overview

Kopran is a fully integrated Indian pharmaceutical company commercializing an extensive portfolio of finished dosage forms and active pharmaceutical ingredients (APIs) globally, with facilities accredited by major international regulatory agencies. Kopran products are marketed in over 60 countries and the company focuses on both regulated and emerging markets, with a particular strength in generic solid oral dosages and dry powder formulations in the antibiotics and cardiovascular areas[1][3][5][7].

Therapeutic areas: EndocrinologyRheumatologyInfectious DiseasesCardiovascularOtherNeurology
Modalities: Small molecule
Industry: Biotech

Beyond the preview

Go deeper on Kopran.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kopran.

Explore the full profile